Objective-To assess the morphology of fossa ovalis atrial septal defects (FOASD; secundum atrial septal defect) to determine in what proportion percutaneous closure with the clam-shell device might be feasible.
Atrial septal defect is the fifth most common congenital heart abnormality at birth and occurs with a frequency of 3.2/10 000 live births. Because ofthe effects ofchronic volume overload of the right ventricle, surgical closure had been recommended for all but the smallest of defects. 2 The safety and benefits of surgical treatment have been well documented. 3 After the successful introduction of interventional cardiac catheter techniques to treat congenital heart disease, methods were evolved for closure of atrial septal defects percutaneously. ' (3) Inferior FOASD In eight patients the atrial septal defect extended inferiorly and was close to the orifice of the inferior caval vein in six patients (5 7%) and coronary sinus in two patients (1-9%). In these two patients, the edge of the defects was described by the surgeon as within 2-0 mm of the orifice of the coronary sinus. In these eight patients the application of the clam-shell could obstruct the orifice of these structures (fig 2b) .
(4) Posterior FOA SD The posterior limbus of the atrial septum was severely attenuated in two patients (1-9%), so much so that the atrial septal defect extended posteriorly with its posterior edge being formed by the posterior atrial wall. This posterior edge was very close to the right pulmonary veins in both these cases. These defects were considered to be unsuitable for closure with the clam-shell device as the defects lacked a posterior rim for fixation of the device and also it could obstruct the right pulmonary veins (fig 2c) . In the remaining 47 patients it was postulated that transcatheter closure with the clamshell device could not be performed safely.
Discussion
Our study confirms the great variability in the anatomy of the FOASD in our patients. Even though the most common variation is a single central defect located within the confines of the fossa ovalis, some of the defects extended beyond its margins. This observation is in agreement with reports based on necropsy specimens.7 13 Depending on the degree to which it extends beyond the confines of the fossa ovalis, the defect may be close to the coronary sinus, infeior caval vein, or the right pulmonary veins; placement of a clam-shell device may then obstruct these structures. Some defects were very large with considerable attenuation of the limbus. They are similar to the common atrium haemodynamically but anatomically they are different and do not possess the other features of an atrioventricular septal defect.'4 It would not be possible to close these defects with the clam-shell device because of an insufficient rim for fixation of the device. The fenestrated atrial septal defect poses a problem for the cardiologist contemplating transcatheter closure. Its margins are not well defined by transthoracic echocardiography and may lead to inaccurate sizing. Perhaps when its anatomy and size can be more reliably evaluated with the newer imaging techniques, such as transoesophageal echocardiography, it may then be possible to close some of these defects with the clam-shell device.
One of the most important criteria for suitability of transcatheter closure with the clam-shell is the size of the defect. Cross sectional echocardiography from the subxiphoid position has been shown to be very accurate in defining the morphology of atrial septal defects; so much so that cardiac catheterisation is no longer needed before surgery.'1'7
The addition of Doppler colour flow mapping has enhanced the diagnostic accuracy of cross sectional echocardiography and may improve the accuracy of diagnosis of fenestrated FOASD.'8 Unfortunately, due to the limitations of the subxiphoid and transthoracic window, not all the information can be obtained by routine cross sectional echocardiography in every patient. Transoesophageal echocardiography enables the operator to image the atrial septum in total with the added advantages that the ultrasound beam is perpendicular to the atrial septum and without interference from lung tissue. Therefore a superior image quality and perhaps a more accurate estimation of the size of the defect may be obtained. Hellenbrand et al have suggested that the concomitant use of transoesophageal echocardiography may also increase the efficacy and safety ofthe transcatheter technique for closure of an atrial septal defect because of more accurate placement of the device. 20 We have conducted a preliminary study of transoesophageal echocardiography with a biplane probe to define the morphology of the atrial septal defect and have reported its accuracy.2' Transoesophageal echocardiography with the biplane transducer in our opinion is the most accurate method for defining the margins and sizing of an atrial septal defect, and its use is mandatory for accurate placement of the device at the time of the procedure.
In our study we have principally based our assessment of suitability for using the clamshell device on the size of the defect and an analysis of contiguous right atrial structures and the degree of proximity of the right pulmonary veins but the other left atrial structures should also be considered as conceivably they may also be obstructed by the device. It must be pointed out that surgical measurements were made with an empty and relaxed heart. In real life the hearts are filled and the defects may be more circular.22
In conclusion, we found significant variability in the morphology of FOASD that may influence the feasibility of transcatheter closure with the clam-shell device. Based on the 81 defects in which the dimensions were recorded by the surgeons, it was postulated that only about 42% of FOASD may be suitable for transcatheter closure. If, however, we include the remaining 25 patients with unknown diameter but were described as having small defects, the final proportion suitable for transcatheter closure would be slightly greater than 50%. Preclosure evaluation should include accurate assessment of the maximum size of the defect and also the proximity of important atrial structures. The technique of choice for this purpose is most likely to be combined transthoracic and transoesophageal cross sectional echocardiography with colour flow Doppler.
